VRBCF · Virbac SA/ADR
Market Cap
$3.21B
Shares
8.38M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$383.25
Open$413.75
Day$382.75–413.75
Available close range$383.25–408.00
Avg vol 30d37
Short int2K · 0.0% float
Short vol100%
DataJul 2020–Jul 2026
The closing range uses available history since Mar 23, 2026; less than a full year is stored.
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.8 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
RSI (14)
59
neutral
52-week position
0%
near low
Momentum
relative strength
1-month return
+18%
trailing
YTD return
+11%
this year
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.02% of float · ▲ +16.7% MoM · 1000.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
No 13F holder history
Squeeze score
24
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
184%
annualized · 1-yr
Max drawdown
−34%
past year
ATR
6.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
RSI (14)
59
Neutral
52-week position
0%
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.02% of float · ▲ +16.7% MoM · 1000.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
No 13F holder history
Price context
position in its available closing range
Range low $383
Now $383 · 0%
Range high $408
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - General — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VRBCF
this stock
Virbac SA/ADR
|
$3.21B | — | — | — | 0.0% |
|
LLY
ELI LILLY & Co
|
$1.09T | +7.3% | +44.7% | 38.7 | 0.8% |
|
JNJ
Johnson & Johnson
|
$650.65B | +30.5% | +6.0% | 31.4 | 0.9% |
|
ABBV
AbbVie Inc.
|
$464.82B | +15.5% | +8.6% | 74.3 | 1.1% |
|
MRK
Merck & Co., Inc.
|
$357.37B | +39.5% | +1.3% | 115.9 | 1.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VRBCF | +18.1% | +18.3% | — | -6.1% | +10.8% |
| SPY | -1.0% | +1.9% | +7.5% | +0.1% | +9.6% |
| vs SPY | +19.1% | +16.4% | — | -6.2% | +1.2% |